Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Immunex Corp. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Johnson & Johnson et al. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Merck Sharp & Dohme Corp | Merck | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
Sandoz, Inc. | Sandoz Group | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
Sandoz, Inc. | Sandoz Group | pharmaceuticals | HHS civil monetary penalties | 2011 | HHSOIG | $230,000 |
Mallinckrodt, Inc. | Mallinckrodt | pharmaceuticals | radioactive waste violation | 2008 | GA-ENV | $5,000 |
Merck & Company, Incorporated | Merck | pharmaceuticals | hazardous waste violation | 2000 | GA-ENV | $40,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
Mylan Laboratories, Inc. | Viatris | pharmaceuticals | consumer protection violation | 2000 | FTC | $100,000,000 |
PHIBRO-TECH, INC. | Phibro Animal Health | pharmaceuticals | railroad safety violation | 2008 | FRA | $5,650 |
Mallinckrodt | Mallinckrodt | pharmaceuticals | railroad safety violation | 2007 | FRA | $10,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | railroad safety violation | 2002 | FRA | $11,250 |
Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | railroad safety violation | 2006 | FRA | $6,800 |
Cherokee Pharmaceuticals | Merck | pharmaceuticals | railroad safety violation | 2021 | FRA | $5,000 |
Malincrodt Chemical Company | Mallinckrodt | pharmaceuticals | railroad safety violation | 2022 | FRA | $7,500 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | pharmaceuticals | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | pharmaceuticals | motor vehicle safety violation | 2006 | FMCSA | $7,614 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | pharmaceuticals | motor vehicle safety violation | 2005 | FMCSA | $15,820 |
EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | pharmaceuticals | motor vehicle safety violation | 2004 | FMCSA | $13,170 |
Cody Laboratories Inc | Lannett Co. | pharmaceuticals | motor vehicle safety violation | 2018 | FMCSA | $8,510 |
VISTAKON | Johnson & Johnson | pharmaceuticals | hazardous waste violation | 2005 | FL-DEP | $9,771 |
ANDRX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | hazardous waste violation | 2001 | FL-DEP | $15,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2004 | FL-AG | $807,826 |
General Nutrition Corp. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2002 | FL-AG | $1,000,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | pharmaceuticals | campaign finance violation | 2007 | FEC | $9,000 |
Astellas Pharma US, Inc. | Astellas Pharma | pharmaceuticals | campaign finance violation | 2022 | FEC | $7,500 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
Genzyme Corporation | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Scios Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | FDA | $41,500,000 |
Warner Chilcott PLC | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | pharmaceuticals | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
Wyeth-Ayerst Laboratories Division | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
ETHICON ENDO SURGERY | Johnson & Johnson | pharmaceuticals | aviation safety violation | 2010 | FAA | $5,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $6,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $15,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2011 | FAA | $30,000 |
SIGMA-ALDRICH INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $8,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $11,000 |
BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | pharmaceuticals | aviation safety violation | 2014 | FAA | $15,000 |
GLAXO SMITH KLINE | GlaxoSmithKline | pharmaceuticals | aviation safety violation | 2014 | FAA | $59,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2016 | FAA | $7,500 |
MERCK & CO. | Merck | pharmaceuticals | aviation safety violation | 2015 | FAA | $65,000 |
MERCK & CO. INC. | Merck | pharmaceuticals | aviation safety violation | 2015 | FAA | $65,000 |
SIGMA-ALDRICH, INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2017 | FAA | $5,000 |
Merck | Merck | pharmaceuticals | environmental violation | 2011 | EPA | $1,500,000 |
King Pharmaceuticals LLC | Pfizer | pharmaceuticals | air pollution violation | 2013 | EPA | $2,200,000 |
GlaxoSmithKline Vaccines | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | $172,900 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | $317,550 |
Advanced Sterilization Products | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | EPA | $136,800 |
Pfizer Pharmaceuticals LLC | Pfizer | pharmaceuticals | air pollution violation | 2014 | EPA | $728,000 |
EMD Millipore Corporation | Merck KGaA (EMD) | pharmaceuticals | pesticide violation | 2013 | EPA | $2,681,500 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | $68,475 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $300,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $3,650,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | $975,000 |
Merck | Merck | pharmaceuticals | water pollution violation | 2007 | EPA | $19,750,000 |
EMD Millipore Corp. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2017 | EPA | $385,000 |
Pfizer Pharmaceuticals, LLC | Pfizer | pharmaceuticals | air pollution violation | 2016 | EPA | $190,000 |
CSL Behring, LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | $527,144 |
Genentech | Roche | pharmaceuticals | hazardous waste violation | 2023 | EPA | $158,208 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | $19,538 |
PFIZER INC / GROTON SITE | Pfizer | pharmaceuticals | environmental violation | 2005 | EPA | $22,500 |
PFIZER GLOBAL MANUFACTURING | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
MILLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2010 | EPA | $526,500 |
EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | water pollution violation | 2017 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $385,000 |
MILLIPORE, CIDRA, INC. | Merck KGaA (EMD) | pharmaceuticals | water pollution violation | 2000 | EPA | $9,000 |